Evaluation of efficacy of PS/MAR/HO-1 oil and a marketed formulation in mild to moderate Hair loss in females

A Two Arm, Randomized, Multicenter, Single blind, Prospective, Clinical study to evaluate efficacy & safety of PS/MAR/HO-1 oil and a marketed formulation in mild to moderate Hair loss in females - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2015/12/006462

Enrollment

200

Registered

2015-12-23

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Hair Fall

Interventions

Intervention1: PS/MAR/HO-1 Oil: Amla (Emblica officinalis), Nagarmotha (Cyperus rotundus, Methi (Fenugreek) (Trigonella foenum-graecum), Mehandi (Henna) (Lawsonia inermis), Aloe Vera (Aloe barbadensis

Eligibility

Inclusion criteria

Inclusion criteria: 1. Female subjects between the age group of 18- 40 years both inclusive 2. Subjects suffering from mild to moderate hair loss (by comb test). 3. Subjects who are infrequent hair oil users 4. Subjects who are willing to give informed consent and ready to comply with the protocol 5. Subjects who are ready to provide regular follow ups till the completion of the study

Exclusion criteria

Exclusion criteria: 1. Subjects with severe Hair fall due to any clinically significant disorders. 2. Subject with severe dermatological disorders of the scalp 3. Subjects with recent disease history like, malaria, typhoid, jaundice & scalp diseases 4. Subjects who have regularly used anti-hair fall treatment with hair oils over last 6 months. 5. Subjects who have previously undergone hair transplantation 6. Subjects on immunosuppressive drugs 7. Subjects on systemic steroids for more than 14 days within last 2 months 8. Pregnant/planning a pregnancy or lactating, menopausal Women

Design outcomes

Primary

Measure	Time frame
Assessment of efficacy of PS/MAR/HO-01 oil in mild to moderate hair loss in femalesTimepoint: Day 0, Day 15, Day 30, Day 45, Day 60	—

Secondary

Measure	Time frame
1. Assessment of efficacy of PS/MAR/HO-01 oil in comparison with a marketed preparation 2. Assessment of effect of PS/MAR/HO-01 oil in comparison with and marketed preparation oil on quality of hair based on subject questionnaire including dandruff, greying and hair growth. 3. Global assessment of overall change in hair loss by the physician and subject. 4. Assessment of safety by observing any allergic reactions & adverse eventsTimepoint: Day 0, Day 15, Day 30, Day 45, Day 60	—

Measure

Time frame

1. Assessment of efficacy of PS/MAR/HO-01 oil in comparison with a marketed preparation 2. Assessment of effect of PS/MAR/HO-01 oil in comparison with and marketed preparation oil on quality of hair based on subject questionnaire including dandruff, greying and hair growth. 3. Global assessment of overall change in hair loss by the physician and subject. 4. Assessment of safety by observing any allergic reactions & adverse eventsTimepoint: Day 0, Day 15, Day 30, Day 45, Day 60

—

Countries

India

Contacts

Public ContactDr Sanjay Tamoli

Target Institute of Medical Education and Research

targetinstitute@yahoo.com9322522252

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026